Cargando…
3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis
The introduction of more relevant cell models in early preclinical drug discovery, combined with high-content imaging and automated analysis, is expected to increase the quality of compounds progressing to preclinical stages in the drug development pipeline. In this review we discuss the current swi...
Autores principales: | Booij, Tijmen H., Price, Leo S., Danen, Erik H. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589915/ https://www.ncbi.nlm.nih.gov/pubmed/30817892 http://dx.doi.org/10.1177/2472555219830087 |
Ejemplares similares
-
Development of a 3D Tissue Culture–Based High-Content Screening Platform That Uses Phenotypic Profiling to Discriminate Selective Inhibitors of Receptor Tyrosine Kinases
por: Booij, Tijmen H., et al.
Publicado: (2016) -
Ultra High Content Image Analysis and Phenotype Profiling of 3D Cultured Micro-Tissues
por: Di, Zi, et al.
Publicado: (2014) -
High-Throughput Phenotypic Screening of Kinase Inhibitors to Identify Drug Targets for Polycystic Kidney Disease
por: Booij, Tijmen H., et al.
Publicado: (2017) -
High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids
por: Choo, Nicholas, et al.
Publicado: (2021) -
In vitro 3D phenotypic drug screen identifies celastrol as an effective in vivo inhibitor of polycystic kidney disease
por: Booij, Tijmen H, et al.
Publicado: (2019)